Malik Rajesh — SEC Form 4 filings

SEC reporting owner CIK 1706853. 4 Form 4 filings on record with FilingPulse; latest filed 2024-09-18.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-02-13 to 2024-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
G1 Therapeutics, Inc. (GTHX)Chief Medical Officer43 legs · 39,226 sh · $177,3849

Form 4 filings — Malik Rajesh

FiledFormIssuerReported transactionsSource
2024-09-184G1 Therapeutics, Inc. (GTHX)Grant/award (A): 17,900 · Disposition to issuer (D): 89,762 · Code (U): 87,450 · Disposition to issuer (D): 74,500 (derivative) · Disposition to issuer (D): 35,700 (derivative) · Disposition to issuer (D): 57,333 (derivative) · +1 moreEDGAR
2024-07-084G1 Therapeutics, Inc. (GTHX)Sale (S): 2,475 @ $2.51EDGAR
2024-05-154G1 Therapeutics, Inc. (GTHX)Sale (S): 8,151 @ $4.79EDGAR
2024-02-134G1 Therapeutics, Inc. (GTHX)Option exercise (M): 28,600 @ $0.30 · Sale (S): 28,600 @ $4.62 · Option exercise (M): 28,600 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1706853 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →